262 related articles for article (PubMed ID: 22341540)
41. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
42. [Gastroesophageal reflux in adults: diagnosis and treatment. Conclusions of Consensus Conference: long text. Organized by the French National Society of Gastroenterology and Belgian Royal Society of Gastroenterology/Flemish Society of Gastroenterology. French Society of Digestive Surgery. French Society of Digestive Endoscopy. French Society of Pharmacology].
Gastroenterol Clin Biol; 1999 Jan; 23(1):56-65. PubMed ID: 10219605
[No Abstract] [Full Text] [Related]
43. WITHDRAWN: Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years.
Craig WR; Hanlon-Dearman A; Sinclair C; Taback SP; Moffatt M
Cochrane Database Syst Rev; 2010 May; 2010(5):CD003502. PubMed ID: 20464724
[TBL] [Abstract][Full Text] [Related]
44. [Gastroesophageal reflux disease--diagnostic and therapeutic problems].
Bukowska L; Korzonek M; Szmatłoch E
Przegl Lek; 2002; 59(2):98-103. PubMed ID: 12152259
[TBL] [Abstract][Full Text] [Related]
45. Novel pharmaceutical approaches to reflux disease.
Dutta U; Armstrong D
Gastroenterol Clin North Am; 2013 Mar; 42(1):93-117. PubMed ID: 23452633
[TBL] [Abstract][Full Text] [Related]
46. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
47. A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants.
Tan J; Jeffries S; Carr R
Paediatr Drugs; 2023 Sep; 25(5):557-576. PubMed ID: 37458926
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis and treatment of respiratory symptoms of initially unsuspected gastroesophageal reflux in infants.
Krishnamoorthy M; Mintz A; Liem T; Applebaum H
Am Surg; 1994 Oct; 60(10):783-5. PubMed ID: 7944042
[TBL] [Abstract][Full Text] [Related]
49. The diagnosis and management of gastro-oesophageal reflux in infants.
Vandenplas Y; Salvatore S; Hauser B
Early Hum Dev; 2005 Dec; 81(12):1011-24. PubMed ID: 16278060
[TBL] [Abstract][Full Text] [Related]
50. Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009].
De Bruyne P; Christiaens T; Vander Stichele R; Van Winckel M
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):220-5. PubMed ID: 24464148
[TBL] [Abstract][Full Text] [Related]
51. PHARMACOLOGICAL TREATMENT OF CHILDREN WITH GASTRO-ESOPHAGEAL REFLUX: A SUMMARY.
Gaines C
Gastroenterol Nurs; 2016; 39(1):68-70. PubMed ID: 26825568
[No Abstract] [Full Text] [Related]
52. Bone up on proton pump inhibitors and fracture risk.
Gendreau-Webb R
Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
[No Abstract] [Full Text] [Related]
53. Gastroesophageal reflux in infancy. A common but challenging presentation.
Weill V
Adv Nurse Pract; 2008 Jan; 16(1):47-50. PubMed ID: 20014742
[No Abstract] [Full Text] [Related]
54. New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D; Sifrim D
Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
[TBL] [Abstract][Full Text] [Related]
55. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
Dajani EZ
J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
[TBL] [Abstract][Full Text] [Related]
56. [Gastroesophageal reflux in infants: myths and realities].
Baudon JJ
Arch Pediatr; 2009 May; 16(5):468-73. PubMed ID: 19303264
[TBL] [Abstract][Full Text] [Related]
57. [Medical treatment of gastroesophageal reflux by prokinetic drugs].
Coffin B
Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S90-6. PubMed ID: 10078437
[No Abstract] [Full Text] [Related]
58. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
59. [Therapy of gastroesophageal reflux disease (GERD)].
Storr M
Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
[TBL] [Abstract][Full Text] [Related]
60. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
